Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PGL2001 + NETA for Endometriosis Symptoms
NCT01631981Phase 2Completed
- Sponsor
- PregLem
- Start
- Jun 2012
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 2, randomised, double-blind trial in endometriosis comparing PGL2001 + NETA with Placebo + NETA (2 arms). Primary endpoint: Non-menstrual pelvic pain at 16 weeks. Started Jun 2012; status: completed.
02
Drugs
Estradiol sulfamate
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT01631981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01631981.